Keir Loiacono
Chief Executive Officer at BlueSphere Bio, Inc.
Profile
Keir Loiacono is currently the Chief Executive Officer at BlueSphere Bio, Inc. and also serves as a Director at EpiAxis Therapeutics Pty Ltd.
Previously, he worked as the Chief Compliance Officer & Vice President-Legal at OncoSec Medical, Inc. and as the Head-Legal at Advaxis, Inc. Mr. Loiacono completed his undergraduate degree at Manhattan College and his graduate degree at Pace Law School.
Keir Loiacono active positions
| Companies | Position | Start |
|---|---|---|
BlueSphere Bio, Inc.
 BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Chief Executive Officer | 03/10/2022 |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Director/Board Member | - |
Former positions of Keir Loiacono
| Companies | Position | End |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | General Counsel | - |
| ONCOSEC MEDICAL INCORPORATED | Compliance Officer | - |
Training of Keir Loiacono
| Manhattan College | Undergraduate Degree |
| Pace Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| Private companies | 3 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Health Technology |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Keir Loiacono
